CASCADES, a novel SOX2 super-enhancer associated long noncoding RNA, regulates cancer stem cell specification and differentiation in glioblastoma multiforme

Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor in adults, with a median survival of just over one year. The failure of available treatments to achieve remission in patients with GBM has been attributed to the presence of cancer stem cells (CSCs), which are thought to play a central role in tumor development and progression and serve as a treatment-resistant cell repository capable of driving tumor recurrence; in fact, the property of “stemness” itself may be responsible for treatment resistance. In this study, we identify a novel lncRNA, Cancer stem cell associated distal enhancer of SOX2 (CASCADES) that functions as an epigenetic regulator in glioma CSCs (GSCs). CASCADES is expressed in IDH-wild type GBM and significantly enriched in GSCs. Knockdown of CASCADES in GSCs results in differentiation towards a neuronal lineage in a cell- and cancer-specific manner. Bioinformatics analysis reveals that CASCADES functions as a super-enhancer associated lncRNA epigenetic regulator of SOX2. Our findings identify CASCADES as a critical regulator of stemness in GSCs and represent a novel epigenetic and therapeutic target for disrupting the cancer stem cell compartment in GBM.

[1]  I. Tirosh,et al.  The Glioma Stem Cell Model in the Era of Single-Cell Genomics. , 2020, Cancer cell.

[2]  F. Rigo,et al.  Directed RNase H Cleavage of Nascent Transcripts Causes Transcription Termination. , 2020, Molecular cell.

[3]  J. Mendell,et al.  Antisense-Mediated Transcript Knockdown Triggers Premature Transcription Termination. , 2020, Molecular cell.

[4]  H. Juan,et al.  Investigating the role of super-enhancer RNAs underlying embryonic stem cell differentiation , 2019, BMC Genomics.

[5]  Y. Cao,et al.  LncRNA SNHG20 promotes tumorigenesis and cancer stemness in glioblastoma via activating PI3K/Akt/mTOR signaling pathway. , 2019, Neoplasma.

[6]  Palaniraja Thandapani.  Super-enhancers in cancer. , 2019, Pharmacology & therapeutics.

[7]  Ting Wang,et al.  WashU Epigenome Browser update 2019 , 2019, Nucleic Acids Res..

[8]  J. Rich,et al.  Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer , 2019, Genes & development.

[9]  Ç. Biray Avcı,et al.  Cancer stem cells: A brief review of the current status. , 2019, Gene.

[10]  Helen Y Wang,et al.  Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma , 2018, Front. Immunol..

[11]  Richard A. Moore,et al.  High-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastoma , 2018, bioRxiv.

[12]  M. Fullwood,et al.  Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma. , 2018, Gastroenterology.

[13]  J. Mendell,et al.  Functional Classification and Experimental Dissection of Long Noncoding RNAs , 2018, Cell.

[14]  Daniel S. Day,et al.  YY1 Is a Structural Regulator of Enhancer-Promoter Loops , 2017, Cell.

[15]  C. Brennan,et al.  Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence , 2017, Nature Genetics.

[16]  K. Hansen,et al.  Linear models enable powerful differential activity analysis in massively parallel reporter assays , 2017, BMC Genomics.

[17]  Richard A. Moore,et al.  Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy , 2017, Nature.

[18]  A. Bhan,et al.  Long Noncoding RNA and Cancer: A New Paradigm. , 2017, Cancer research.

[19]  Guo-Cheng Yuan,et al.  Dissecting super-enhancer hierarchy based on chromatin interactions , 2017, Nature Communications.

[20]  Satyaki Sengupta,et al.  Super-Enhancer-Driven Transcriptional Dependencies in Cancer. , 2017, Trends in cancer.

[21]  R. Young,et al.  Transcriptional Addiction in Cancer , 2017, Cell.

[22]  H. Poulsen,et al.  Hallmarks of glioblastoma: a systematic review , 2016, ESMO Open.

[23]  K. Soo,et al.  Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity , 2016, Nature Communications.

[24]  James T. Robinson,et al.  Juicebox Provides a Visualization System for Hi-C Contact Maps with Unlimited Zoom. , 2016, Cell systems.

[25]  J. Taipale,et al.  The role of enhancers in cancer , 2016, Nature Reviews Cancer.

[26]  Brian D. Bennett,et al.  INO80 governs superenhancer-mediated oncogenic transcription and tumor growth in melanoma , 2016, Genes & development.

[27]  P. Ivanov,et al.  The Long Non-coding RNA HIF1A-AS2 Facilitates the Maintenance of Mesenchymal Glioblastoma Stem-like Cells in Hypoxic Niches. , 2016, Cell reports.

[28]  C. Blanpain,et al.  Cancer Stem Cells: Basic Concepts and Therapeutic Implications. , 2016, Annual review of pathology.

[29]  Ming-Rong Wang,et al.  Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma , 2016, Gut.

[30]  Hong-Wei Xue,et al.  Arabidopsis PROTEASOME REGULATOR1 is required for auxin-mediated suppression of proteasome activity and regulates auxin signalling , 2016, Nature Communications.

[31]  Howard Y. Chang,et al.  Long Noncoding RNAs in Cancer Pathways. , 2016, Cancer cell.

[32]  M. Rosenfeld,et al.  Enhancers as non-coding RNA transcription units: recent insights and future perspectives , 2016, Nature Reviews Genetics.

[33]  Roland Eils,et al.  Active medulloblastoma enhancers reveal subgroup-specific cellular origins , 2016, Nature.

[34]  R. Guigó,et al.  CARMEN, a human super enhancer-associated long noncoding RNA controlling cardiac specification, differentiation and homeostasis. , 2015, Journal of molecular and cellular cardiology.

[35]  M. Behlke,et al.  Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides , 2015, Nucleic acids research.

[36]  R. Young,et al.  CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer , 2015, Cell.

[37]  David Z. Pan,et al.  Genome-wide analysis of enhancer RNA in gene regulation across 12 mouse tissues , 2015, Scientific Reports.

[38]  J. Rich,et al.  Cancer stem cells in glioblastoma , 2015, Genes & development.

[39]  Gelareh Zadeh,et al.  Glioblastoma: pathology, molecular mechanisms and markers , 2015, Acta Neuropathologica.

[40]  Z. Werb,et al.  The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? , 2015, Cell stem cell.

[41]  Sandra Macedo-Ribeiro,et al.  Structure of mycobacterial maltokinase, the missing link in the essential GlgE-pathway , 2015, Scientific Reports.

[42]  J. Lieb,et al.  What are super-enhancers? , 2014, Nature Genetics.

[43]  Bing Ren,et al.  CRISPR Reveals a Distal Super-Enhancer Required for Sox2 Expression in Mouse Embryonic Stem Cells , 2014, PloS one.

[44]  Yan Liu,et al.  Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor. , 2014, Cancer cell.

[45]  Bandana Sharma,et al.  CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer , 2014, Cell.

[46]  Howard Y. Chang,et al.  Long noncoding RNAs in cell-fate programming and reprogramming. , 2014, Cell stem cell.

[47]  C. Glass,et al.  Enhancer RNAs and regulated transcriptional programs. , 2014, Trends in biochemical sciences.

[48]  Simon Kasif,et al.  Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells , 2014, Cell.

[49]  Junhui Ge,et al.  Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus , 2014, Cell Research.

[50]  F. De Filippis,et al.  A Selected Core Microbiome Drives the Early Stages of Three Popular Italian Cheese Manufactures , 2014, PloS one.

[51]  Daniel R. Zerbino,et al.  Ensembl 2014 , 2013, Nucleic Acids Res..

[52]  R. Young,et al.  Super-Enhancers in the Control of Cell Identity and Disease , 2013, Cell.

[53]  C. Blanpain,et al.  Unravelling cancer stem cell potential , 2013, Nature Reviews Cancer.

[54]  D. Bartel,et al.  lincRNAs: Genomics, Evolution, and Mechanisms , 2013, Cell.

[55]  Yue Wang,et al.  Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. , 2013, Developmental cell.

[56]  O. Sampetrean,et al.  Characteristics of glioma stem cells , 2013, Brain Tumor Pathology.

[57]  David A. Orlando,et al.  Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes , 2013, Cell.

[58]  J. Rutka,et al.  Glioblastoma, a Brief Review of History, Molecular Genetics, Animal Models and Novel Therapeutic Strategies , 2013, Archivum Immunologiae et Therapiae Experimentalis.

[59]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[60]  Howard Y. Chang,et al.  Genome regulation by long noncoding RNAs. , 2012, Annual review of biochemistry.

[61]  S. Berger,et al.  IDH mutation impairs histone demethylation and results in a block to cell differentiation , 2012, Nature.

[62]  J. Rinn,et al.  Modular regulatory principles of large non-coding RNAs , 2012, Nature.

[63]  H. Fine,et al.  Cancer stem cells in gliomas: Identifying and understanding the apex cell in cancer's hierarchy , 2011, Glia.

[64]  J. Rinn,et al.  lincRNAs act in the circuitry controlling pluripotency and differentiation , 2011, Nature.

[65]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[66]  J. Rinn,et al.  Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression , 2009, Proceedings of the National Academy of Sciences.

[67]  Sunit Das,et al.  Cancer stem cells and glioma , 2008, Nature Clinical Practice Neurology.

[68]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[69]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[70]  Mitchel S Berger,et al.  Neural stem cells and the origin of gliomas. , 2005, The New England journal of medicine.

[71]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[72]  A. N. James.  What’s in a Dream , 1890, Hall's journal of health.

[73]  J. Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. , 2019, Neuro-oncology.

[74]  M. Wood,et al.  Antisense oligonucleotides: the next frontier for treatment of neurological disorders , 2018, Nature Reviews Neurology.

[75]  F. Yamasaki,et al.  Permeability Surface Area Product Using Perfusion Computed Tomography Is a Valuable Prognostic Factor in Glioblastomas Treated with Radiotherapy Plus Concomitant and Adjuvant Temozolomide. , 2017, World neurosurgery.